GlassScriptPrepare for your visit
Susan L Mcelroy
Psychiatry · Mason, OH · NPI 1841385986
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$39,346.73
in general payments reported to CMS, 2019-2025 · $2,239 in 2025
The $2,239 reported for 2025 was more than what 90% of Psychiatry providers received nationally (typical 2025 total: $176).
Who reported paying
General payments only, top 6 by amount.
- Janssen Research & Development, LLC $9,255.80
- Sunovion Pharmaceuticals INC. $5,428.26
- Otsuka Pharmaceutical Development & Commercialization, INC. $5,104.74
- Shire North American Group INC $3,600.00
- Novo Nordisk As $3,200.00
- Mitsubishi Tanabe Pharma Development America, INC. $2,500.00
Drugs and devices associated with these payments
Auvelity
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Susan Mcelroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/265674/susan-l-mcelroy